Zydus Lifesciences Limited Hydroxychloroquine Export Data — India (DGFT 2022–2026)

Name: Zydus Lifesciences Limited Hydroxychloroquine Export Records India — #1 Exporter, 259 Shipments, $12.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Hydroxychloroquine

India Pharmaceutical Trade Intelligence

$141.5M163 Suppliers86 CountriesHS 30049099

ExportsIndia → UNITED STATES89.2%India → UNITED KINGDOM1.9%

ImportsUNITED STATES → India$9.0K THAILAND → India$1.5K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Zydus Lifesciences Limited — Hydroxychloroquine Exporter #1 | $12.9M Trade Value | TransData Nexus | TransData Nexus

Zydus Lifesciences Limited — Hydroxychloroquine Exporter Profile

Indian Pharmaceutical Exporter · #1 for Hydroxychloroquine · $12.9M export value · DGFT Verified

Zydus Lifesciences Limited is the #1 Indian exporter of Hydroxychloroquine with $12.9M in export value and 259 verified shipments. Zydus Lifesciences Limited holds a 9.2% market share in Hydroxychloroquine exports across 8 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.

Zydus Lifesciences Limited — Hydroxychloroquine Export Profile: Buyers & Destinations

Zydus Lifesciences Limited Hydroxychloroquine export treemap — buyers and destination countries | TransData Nexus

Where Does Zydus Lifesciences Limited Export Hydroxychloroquine?

Country	Value	Shipments	Share
UNITED STATES	$10.6M	216	87.2%
THAILAND	$411.9K	12	3.4%
VIETNAM, DEMOCRATIC REP. OF	$330.9K	8	2.7%
ALGERIA	$300.0K	6	2.5%

Who Are the Top Buyers of Hydroxychloroquine from Zydus Lifesciences Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$8.1M	164
NORTHSTAR DISTRIBUTION CENTER 8912	UNITED STATES	$1.6M	33
HAPHARCO J.S.C. BRANCH	VIETNAM, DEMOCRATIC REP. OF	$360.8K	9
EVERSANA LIFE SCIENCE SERVICES,	UNITED STATES	$350.0K	7
KASPA PHARMACEUTICAL (THAILAND)	THAILAND	$301.3K	8
PRIORITY HEALTHCARE DISTRIBUTION DB	UNITED STATES	$300.0K	6
SARL CPCM	ALGERIA	$200.0K	4
CHEMILL PHARMA LTD	HONG KONG	$150.0K	3
PRIORITY HEALTHCARE DISTRIBUTION	UNITED STATES	$150.0K	3
GUJARAT	UNITED STATES	$133.5K	3

Zydus Lifesciences Limited supplies Hydroxychloroquine to 19 buyers globally. The largest buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES) and HAPHARCO J.S.C. BRANCH (VIETNAM, DEMOCRATIC REP. OF). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Hydroxychloroquine Formulations Does Zydus Lifesciences Limited Export?

Product Description / Formulation	Value	Shipments
HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG	$1.1M	23
HYDROXYCHLOROQUINE SULFATE TABLETS USP 2	$753.4K	17
HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG (OTHER DETAILS AS PER INV & P.LIST)	$541.5K	11
PHARMA : HYDROXYCHLOROQUINE SULFATE TABL	$500.0K	10
PHARMACEUTICAL MEDICINE FOR HUMAN USE -HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG 1 X 100T	$491.1K	10
HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MGTBS	$450.0K	9
PHARMACEUTICAL MEDICINE FOR HUMAN USE -HYDROXYCHLOROQUINE SULFATE TABLETS USP 200 MG - 1 X 500	$320.0K	7
PHARMACEUTICAL MEDICINE FOR HUMAN USE- HYDROXYCHLOROQUINE SULFATE TABLETS USP 200 MG - 1 X 500NOS	$300.0K	6
HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG OTHER DTLS AS PER INVOICENOS	$300.0K	6
PHARMACEUTICAL MEDICINE FOR HUMAN USE -HYDROXYCHLOROQUINE SULFATE TABLETS USP 200 MG - 1 X 500NOS	$300.0K	6

Zydus Lifesciences Limited exports 97 distinct Hydroxychloroquine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG with 23 shipments worth $1.1M.

How Does Zydus Lifesciences Limited Compare to Nearest Hydroxychloroquine Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	ZYDUS LIFESCIENCES LIMITED ★	$12.9M	259	8	$50.0K
2	IPCA LABORATORIES LIMITED	$7.3M	146	11	$50.0K
3	CADILA HEALTHCARE LIMITED	$2.0M	40	5	$50.0K

Zydus Lifesciences Limited ranks #1 among 163 Indian Hydroxychloroquine exporters. Average shipment value of $50.0K compared to the market average of $159.2K. The closest competitors by value are IPCA LABORATORIES LIMITED and CADILA HEALTHCARE LIMITED.

Which Indian Ports Ship Hydroxychloroquine Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	935	25.2%
SAHAR AIR	756	20.3%
DELHI AIR CARGO ACC (INDEL4)	610	16.4%
DELHI AIR	305	8.2%
Bombay Air	285	7.7%
MUNDRA SEA	137	3.7%
Delhi Air	116	3.1%
NHAVA SHEVA SEA (INNSA1)	76	2.0%

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Hydroxychloroquine Exports

Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.

Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)

These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Hydroxychloroquine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 259 individual customs records matching Zydus Lifesciences Limited exporting Hydroxychloroquine, covering 97 formulations to 10 countries via 19 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 86+ countries, 271+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Hydroxychloroquine

Hydroxychloroquine

Zydus Lifesciences Limited — Hydroxychloroquine Exporter Profile

Zydus Lifesciences Limited — Hydroxychloroquine Export Profile: Buyers & Destinations

Where Does Zydus Lifesciences Limited Export Hydroxychloroquine?

Who Are the Top Buyers of Hydroxychloroquine from Zydus Lifesciences Limited?

What Is India's Total Hydroxychloroquine Export Value and How Much Does Zydus Lifesciences Limited Contribute?

What Is the Average Shipment Value for Zydus Lifesciences Limited's Hydroxychloroquine Exports?

How Does Zydus Lifesciences Limited Compare to Other Indian Hydroxychloroquine Exporters?

What Hydroxychloroquine Formulations Does Zydus Lifesciences Limited Export?

Regulatory Requirements: Exporting Hydroxychloroquine to Key Markets

United States — FDA

How Does Zydus Lifesciences Limited Compare to Nearest Hydroxychloroquine Exporters?

Which Indian Ports Ship Hydroxychloroquine Exports?

What Other Antimalarial & Antiparasitic Products Does Zydus Lifesciences Limited Export?

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Hydroxychloroquine Exports

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

About Zydus Lifesciences Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Hydroxychloroquine Export Data from Zydus Lifesciences Limited

Hydroxychloroquine Stats

Company Overview

Top Products by Zydus Lifesciences Limited

Related Analysis

Need Detailed Export Data?

Data Source